CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
1,619,407
Share change
+207,468
Total reported value
$29,390,912
Price per share
$18.15
Number of holders
38
Value change
+$3,751,127
Number of buys
22
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q3 2018

As of 30 Sep 2018, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,619,407 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, DEUTSCHE BANK AG\, SCHWAB CHARLES INVESTMENT MANAGEMENT INC, and DIMENSIONAL FUND ADVISORS LP. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.